Pro-Neuron, Inc.
Records under this name other than patents Pro-Neuron, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,307,166 | Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis Formerly held Lapsed on the fee record Ended Dec 11, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 11, 2019 | From the USPTO record |
| US 6,956,028 | Compositions and Methods for Treatment of Mitochondrial Diseases Formerly held Term ended Term ended Oct 23, 2019 · Medium confidence | Term ended | Term ended Oct 23, 2019 | Medium confidence |
| US 6,316,426 | Acylated uridine and cytidine and uses thereof Formerly held Term ended Term ended Nov 13, 2018 · From the USPTO record | Term ended | Term ended Nov 13, 2018 | From the USPTO record |
| US 7,807,654 | Compositions and Methods for Treatment of Mitochondrial Diseases Formerly held Lapsed on the fee record Ended Oct 5, 2018 · Low confidence | Lapsed on the fee record | Ended Oct 5, 2018 | Low confidence |
| US 7,582,619 | Compositions and Methods for Treatment of Mitochondrial Diseases Formerly held Term ended Ended no later than Sep 25, 2018 · Low confidence | Term ended | Ended no later than Sep 25, 2018 | Low confidence |
| US 6,472,378 | Compositions and methods for treatment of mitochondrial diseases Formerly held Term ended Term ended Aug 31, 2018 · From the USPTO record | Term ended | Term ended Aug 31, 2018 | From the USPTO record |
| US 6,274,563 | Acylated uridine and cytidine and uses thereof Formerly held Term ended Term ended Aug 14, 2018 · From the USPTO record | Term ended | Term ended Aug 14, 2018 | From the USPTO record |
| US 6,258,795 | Acylated uridine and cytidine and uses thereof Formerly held Term ended Term ended Jul 10, 2018 · From the USPTO record | Term ended | Term ended Jul 10, 2018 | From the USPTO record |
| US 6,232,298 | Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis Formerly held Term ended Term ended May 15, 2018 · From the USPTO record | Term ended | Term ended May 15, 2018 | From the USPTO record |
| US 6,090,782 | Hemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferation Formerly held Term ended Term ended Jan 12, 2018 · From the USPTO record | Term ended | Term ended Jan 12, 2018 | From the USPTO record |